Enrique de Ramón Garrido

Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2002 · 1.1K citations · Full text

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, D. D’Cruz et al. · Annals of the Rheumatic Diseases · 2009 · 528 citations

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

Frédéric Houssiau, David D’Cruz, Shirish Sangle et al. · Annals of the Rheumatic Diseases · 2010 · 489 citations · Full text

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2004 · 382 citations · Full text

Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.

M. Galeazzi, Gabriella Morozzi, Gian Domenico Sebastiani et al. · PubMed · 1998 · 108 citations